Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Arrhythmias

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 23 articles: HTML format

Single Articles

June 2008
1. WYSE DG
   Therapeutic Considerations in Applying Rate Control Therapy for Atrial Fibrillation.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. HAMMWOHNER M , Goette A
   Will Warfarin Soon Be Passe? New Approaches to Stroke Prevention in Atrial Fibrillation.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. NATTEL S
   Evolving Developments in the Therapeutics of Atrial Fibrillation: Addressing an Unmet Need.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles   
   
   
   April 2008
4. BILLMAN GE , Kukielka M
   Novel Transient Outward and Ultra-rapid Delayed Rectifier Current Antagonist, AVE0118, Protects Against Ventricular Fibrillation Induced by Myocardial Ischemia.
   J Cardiovasc Pharmacol. 2008;51:352-8.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. PATTERSON E , Lu Z, Lin J, Scherlag BJ, et al
   Antifibrillatory properties of mivacurium in a canine model of atrial fibrillation.
   J Cardiovasc Pharmacol. 2008;51:293-303.
   PubMed     Related articles    Abstract available
   
   
   
6. FOGARI R , Zoppi A, Mugellini A, Corradi L, et al
   Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes Mellitus.
   J Cardiovasc Pharmacol. 2008;51:217-222.
   PubMed     Related articles    Abstract available
   
   
   December 2007
7. TSUKADA YT , Sanna MG, Rosen H, Gottlieb RA, et al
   S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias.
   J Cardiovasc Pharmacol. 2007;50:660-9.
   PubMed     Related articles    Abstract available
   
   
   
8. CHEVALIER P , Dubieff AD, Piqueras E, Pineau J, et al
   The Impact of Acute Myocardial Ischemia on the Ventricular Defibrillation Threshold During Chronic Oral Azimilide Therapy.
   J Cardiovasc Pharmacol. 2007;50:629-632.
   PubMed     Related articles    Abstract available
   
   
   November 2007
9. MALFATTO G , Zaza A, Md MF
   Different Effects of Antiarrhythmic Drugs on the Rate-Dependency of QT Interval: A Study With Amiodarone and Flecainide.
   J Cardiovasc Pharmacol. 2007;50:535-540.
   PubMed     Related articles    Abstract available
   
   
   
10. GROSJEAN N , Vie B, Letienne R, Grand BL, et al
    Effects of SM-20550 Against Myocardial Infarction-induced Arrhythmias, Late Infarct Expansion, and Left Ventricular Dysfunction.
    J Cardiovasc Pharmacol. 2007;50:563-70.
    PubMed     Related articles    Abstract available
    
    
    
11. BOYDEN PA , Davies SS, Viswanathan PC, Amarnath V, et al
    Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias.
    J Cardiovasc Pharmacol. 2007;50:480-6.
    PubMed     Related articles    Abstract available
    
    
    
12. FEINMARK SJ
    Arachidonic Acid metabolites in the cardiovascular system.
    J Cardiovasc Pharmacol. 2007;50:467-9.
    PubMed     Related articles   
    
    
    September 2007
13. FUJIKI A , Sakamoto T, Nishida K, Mizumaki K, et al
    Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    J Cardiovasc Pharmacol. 2007;50:264-6.
    PubMed     Related articles    Abstract available
    
    
    
14. PATTERSON E , Scherlag BJ, Lazzara R, Garrison GL, et al
    Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    J Cardiovasc Pharmacol. 2007;50:304-13.
    PubMed     Related articles    Abstract available
    
    
    July 2007
15. HASHMI-HILL MP , Graves JE, Sandock K, Bates JN, et al
    Hemodynamic Responses Elicited by Systemic Injections of Flavin Adenine Dinucleotide in Anesthetized Rats.
    J Cardiovasc Pharmacol. 2007;50:94-102.
    PubMed     Related articles    Abstract available
    
    
    June 2007
16. BRIGADEAU F , Gele P, Wibaux M, Marquie C, et al
    The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
    J Cardiovasc Pharmacol. 2007;49:408-15.
    PubMed     Related articles    Abstract available
    
    
    May 2007
17. MIKHAIL A , Fischer C, Patel A, Long MA, et al
    Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay.
    J Cardiovasc Pharmacol. 2007;49:269-74.
    PubMed     Related articles    Abstract available
    
    
    April 2007
18. REGAN CP , Stump GL, Wallace AA, Anderson KD, et al
    In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate.
    J Cardiovasc Pharmacol. 2007;49:236-45.
    PubMed     Related articles    Abstract available
    
    
    
19. WIRTH KJ , Brendel J, Steinmeyer K, Linz DK, et al
    In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
    J Cardiovasc Pharmacol. 2007;49:197-206.
    PubMed     Related articles    Abstract available
    
    
    December 2006
20. OHASHI J , Yasuda S, Miyazaki S, Shimizu W, et al
    Prevention of Life-Threatening Ventricular Tachyarrhythmia by a Novel and Pure Class-III Agent, Nifekalant Hydrochloride.
    J Cardiovasc Pharmacol. 2006;48:274-9.
    PubMed     Related articles    Abstract available
    
    
    September 2006
21. CHINUSHI M , Izumi D, Komura S, Ahara S, et al
    Role of Autonomic Nervous Activity in the Antiarrhythmic Effects of Magnesium Sulfate in a Canine Model of Polymorphic Ventricular Tachyarrhythmia Associated with Prolonged QT Interval.
    J Cardiovasc Pharmacol. 2006;48:121-127.
    PubMed     Related articles    Abstract available
    
    
    June 2006
22. MOREIRA TS , Takakura AC, Sato MA, Menani JV, et al
    Antihypertensive Responses Elicited by Central Moxonidine in Rats: Possible Role of Nitric Oxide.
    J Cardiovasc Pharmacol. 2006;47:780-787.
    PubMed     Related articles    Abstract available
    
    
    May 2006
23. TORRES-JACOME J , Tejeda-Chavez HR, Rodriguez-Menchaca AA, Sanchez-Chapula JA, et al
    The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K+ channel.
    J Cardiovasc Pharmacol. 2006;47:656-62.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: